Study assessing Pfizer/BioNTech (BNT162b2) mRNA-based vaccine second-dose immunogenicity and safety, and the relation between them, in patients with systemic autoimmune rheumatic diseases
Latest Information Update: 29 Nov 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Pharmacodynamics
Most Recent Events
- 01 Dec 2022 Results published in the Clinical Rheumatology
- 29 Nov 2022 New trial record